ArticleJournal of experimental & clinical cancer research : CR2022

New molecular mechanisms in cholangiocarcinoma: signals triggering interleukin-6 production in tumor cells and KRAS co-opted epigenetic mediators driving metabolic reprogramming.

Leticia Colyn et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.